Plaque psoriasis is a chronic condition that affects millions yet is often misunderstood or underappreciated in terms of its ...

The actress and entertainment personality partnered with Amgen to share candid glimpses of how she lives with her medical ...

Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...

These 28-week data on twice-daily ESK-001 highlight the drug’s safety and efficacy among patients with psoriasis.

It can turn into chronic plaque psoriasis in some cases, which will require long-term treatment. Guttate psoriasis can emerge temporarily and often goes away on its own. But it’s good to get an ...

Brodalumab is an effective therapy among patients with psoriasis who have failed prior biologic therapy or had risk factors for treatment failure.

The Food and Drug Administration (FDA) has approved Imuldosa ™ (ustekinumab-srlf), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases. Imuldosa, ...

US FDA approves UCB’s 320 mg single-injection device presentations of Bimzelx: Brussels, Belgium Tuesday, October 15, 2024, 13:00 Hrs [IST] UCB, a global biopharmaceutical compa ...

InnoCare Pharma has announced that its Phase II study of the TYK2 inhibitor ICP-488 for psoriasis treatment met the primary ...

“Plaque psoriasis is a chronic inflammatory condition ... “The good news is advances in the field have given us many treatment options. For many patients who struggle with topical therapies ...

Otulfi is approved for the treatment of Crohn’s disease, ulcerative colitis, moderate to severe plaque psoriasis and active ...

This study aims to evaluate the efficacy and safety of picankibart for the treatment of moderately to severely active ulcerative colitis (modified Mayo score of 4 to 9 with an endoscopic subscore of ...